1. Clinical Pharmacokinetics and Pharmacodynamics of Ceftazidime–Avibactam Combination: A Model-Informed Strategy for its Clinical Development

   • Sherwin K. B. Sy
   • Luning Zhuang
   • Hartmut Derendorf

   Review Article 11 August 2018 Pages: 545 - 564

   

2. Cardiovascular Risk Management and Hepatitis C: Combining Drugs

   • Elise J. Smolders
   • Peter J. G. ter Horst
   • David M. Burger

   Review Article Open access 27 September 2018 Pages: 565 - 592

   

3. Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation

   • Camille Tron
   • Florian Lemaitre
   • Eric Bellissant

   Review Article 10 November 2018 Pages: 593 - 613

   

4. Bridging Olaparib Capsule and Tablet Formulations Using Population Pharmacokinetic Meta-analysis in Oncology Patients

   • Diansong Zhou
   • Jianguo Li
   • Hongmei Xu

   Original Research Article 24 October 2018 Pages: 615 - 625

   

5. Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

   • Jurgen B. Langenhorst
   • Thomas P. C. Dorlo
   • Alwin D. R. Huitema

   Original Research Article Open access 17 October 2018 Pages: 627 - 637

   

6. Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus

   • Hanne Haahr
   • Thomas R. Pieber
   • Tim Heise

   Original Research Article Open access 07 November 2018 Pages: 639 - 649

   

7. Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients

   • Sander Bins
   • Alwin D. R. Huitema
   • Stijn L. W. Koolen

   Original Research Article Open access 27 October 2018 Pages: 651 - 658

   

8. Population Pharmacokinetics of the BTK Inhibitor Acalabrutinib and its Active Metabolite in Healthy Volunteers and Patients with B-Cell Malignancies

   • Helena Edlund
   • Sun Ku Lee
   • Nidal Al-Huniti

   Original Research Article 17 December 2018 Pages: 659 - 672

   

9. Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials

   • Yulan Qi
   • Kathleen McKeever
   • Jack Shi

   Original Research Article Open access 23 November 2018 Pages: 673 - 683

   

10. Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials

    • Yulan Qi
    • Kathleen McKeever
    • Jack Shi

    Correction 04 December 2018 Pages: 685 - 685